Evidence map›Paper›PMID 29104815›Full record

ArticleJournal of nanomedicine & nanotechnology2017

A Novel Nano-approach for Targeted Inner Ear Imaging.

M N Kayyali, L Brake, A J Ramsey, A C Wright, B W O'Malley, D Daqing Li

Abstract read
In one paragraph

Article in Journal of nanomedicine & nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The State of High-Resolution Imaging of the Human Inner Ear: A Look Into the Black Box.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Nanoparticles for the Treatment of Inner Ear Infections.Nanomaterials (Basel, Switzerland) · 2021
    Review
  7. Nanocarriers for Inner Ear Disease Therapy.Frontiers in cellular neuroscience · 2021
    Review
  8. Promising Applications of Nanoparticles in the Treatment of Hearing Loss.Frontiers in cell and developmental biology · 2021
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M N KayyaliDepartment of Otolaryngology, Head & Neck Surgery, University of Pennsylvania Health System, Philadelphia, USA.
L BrakeDepartment of Otolaryngology, Head & Neck Surgery, University of Pennsylvania Health System, Philadelphia, USA.
A J RamseyDepartment of Otolaryngology, Head & Neck Surgery, University of Pennsylvania Health System, Philadelphia, USA.
A C WrightDepartment of Radiology, University of Pennsylvania, USA.
B W O'MalleyDepartment of Otolaryngology, Head & Neck Surgery, University of Pennsylvania Health System, Philadelphia, USA.
D Daqing LiDepartment of Otolaryngology, Head & Neck Surgery, University of Pennsylvania Health System, Philadelphia, USA.

Funding

A Novel Regulated Nanohydrogel Delivery System for Targeted Inner Ear ApplicationR01DC014464 · NIDCD · UNIVERSITY OF PENNSYLVANIA · PI LI, DAQING · 2015 to 2019
$2.0M
NIDCD NIH HHS R01 DC014464
6 · The paper itself

Abstract

During the last decade, there have been major improvements in imaging modalities and the development of molecular imaging in general. However detailed inner ear imaging still provides very limited information to physicians. This is unsatisfactory as sensorineural hearing loss is the main cause of permanent hearing loss in adults and at least 134 genetic mutations that result in congenital hearing loss have been identified. We are still unable, in most cases where gross anatomical changes are not observed, to determine the exact cause of hearing loss at a cellular or molecular level in patients using non-invasive techniques. This limitation in inner ear diagnostic modalities is a major obstacle behind the delay in discovering treatments for many of the causes of sensorineural hearing loss. This paper initially investigated the use of targeted gold nanoparticles as contrast agents for inner ear imaging. These nanoparticles have many useful characteristics such as being easy to target and possessing minimal cytotoxicity. We were able to detect the nanoparticles diffusing in the hair cells using confocal microscopy. Regrettably, despite their many admirable characteristics, the gold nanoparticles were unable to significantly enhance CT imaging of the inner ear. Consequently, we investigated liposomal iodine as a potential solution for the unsatisfactory CT contrast obtained with the gold nanoparticles. Fortunately, significant enhancement of the micro-CT image was observed with either Lugol's solution or liposomal iodine, with Lugol's solution enabling fine inner ear structures to be detected.

Indexed as

Gold nanoparticlesInner ear imagingLiposomal iodineTargeted contrast agents

Identifiers

PMID29104815
PMCPMC5669391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.